RxDoctor Payments Data

Stacie Lenssen, MD

Family Medicine · Watertown, SDNPI 1215994769

Payments from drug & device makers

$614in general payments, 2019–2025

Across 41 payments — averaging $14.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$95
  • AbbVie$87
  • Johnson & Johnson$74
  • Pfizer$70
  • Abbott$47
  • Daiichi Sankyo Inc.$30
  • plus $212 from 12 others

What the payments were for

  • Food & beverage$614100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$614 in reported general payments places this provider in the 70th percentile of 408 family medicine providers in South Dakota.

See all family medicine providers in South Dakota

Medicare billing

Part B allowed, 2024
$204,131
Medicare patients
203
Services billed
7,832

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BetaseronInterferon Beta-1b13$133,937
EliquisApixaban106$74,228
OzempicSemaglutide36$39,971
TrulicityDulaglutide34$38,605
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog28$29,344
XareltoRivaroxaban33$19,218
Tresiba Flextouch U-200Insulin Degludec19$15,766
MounjaroTirzepatide15$15,160
JardianceEmpagliflozin14$13,531
MyrbetriqMirabegron22$12,675
Modafinil11$8,800
Novolog Mix 70-30 FlexpenInsulin Aspart Prot/Insuln Asp25$7,742
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$6,804
Levothyroxine Sodium660$5,139
EntrestoSacubitril/Valsartan12$3,712

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$70$74,228106 claims
Novo NordiskOzempic$13$39,97136 claims
Johnson & JohnsonXarelto$74$19,21833 claims
Boehringer IngelheimJardiance$13$13,53114 claims
Astellas Pharma US IncMyrbetriq$17$12,67522 claims
GSKTrelegy Ellipta$28$6,80411 claims
NovartisEntresto$14$3,71212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 408 family medicine providers in South Dakota.

Other family medicine in Watertown

See the full list for South Dakota

Where these figures come from

Is this you, or does something look wrong? →